Download PDF
Appl Clin Inform 2021; 12(02): 320-328
DOI: 10.1055/s-0041-1728698
Research Article

Data Quality of Chemotherapy-Induced Nausea and Vomiting Documentation

Melissa Beauchemin 
1   School of Nursing, Columbia University, New York, New York, United States
2   Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, United States
,
Chunhua Weng
3   Department of Biomedical Informatics, Columbia University, New York, New York, United States
,
Lillian Sung
4   The Hospital for Sick Children, Toronto, Canada
,
Adrienne Pichon
3   Department of Biomedical Informatics, Columbia University, New York, New York, United States
,
Maura Abbott
1   School of Nursing, Columbia University, New York, New York, United States
,
Dawn L. Hershman
2   Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, United States
,
Rebecca Schnall
1   School of Nursing, Columbia University, New York, New York, United States
› Author Affiliations Funding M.B. was supported by the National Institute of Nursing Research Training Grant (NR007969), the National Cancer Institute Training Grant (CA094061), and the Doctoral Degree Scholarship in Cancer Nursing (DSCN-18–068–01) from the American Cancer Society. C.W. was supported by the National Library of Medicine Grant (R01LM009886). R.S. was supported by the National Institute of Nursing Research of the National Institutes of Health under award number K24NR 018621. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health or the American Cancer Society.
› Further Information
   Permissions and Reprints

Abstract

Objective The objective of the study was to characterize the completeness and concordance of the electronic health record (EHR) documentation of cancer symptoms among multidisciplinary health care professionals.

Methods We examined the EHRs of children, adolescents, and young adults who received highly emetogenic chemotherapy and characterized the completeness and concordance of chemotherapy-induced nausea and vomiting (CINV) documentation by clinician type and by the International Classification of Diseases 10th Revision (ICD-10) coding choice.

Results The EHRs of 127 patients, comprising 870 patient notes, were abstracted and reviewed. A CINV assessment was documented by prescribers in 75% of patients, and by nurses in 58% of patients. Of the 60 encounters where both prescribers and nurses documented, 72% agreed on the presence/absence of CINV.

Conclusion Most patients receiving highly emetogenic chemotherapy had a documented assessment of CINV; however, many had incomplete or discordant documentation of CINV from different providers by role, implying the importance of incorporating pragmatic knowledge of EHR documentation patterns among multidisciplinary health professionals for EHR phenotyping and clinical decision support systems directed toward cancer-related symptom management.

Keywords

data quality - electronic health records - clinical informatics - UMLS - cancer symptoms

Protection of Human and Animal Subjects

Protection of human and animal subjects was followed according to the IRB. This study included data that had already been collected for clinical care of included patients, and all data were reported in aggregate to avoid any patient identifiers.




Publication History

Received: 29 October 2020

Accepted: 02 March 2021

Article published online:
21 April 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Tcheng JE, Bakken S, Bates DW. eds. Optimizing Strategies for Clinical Decision Support: Summary of a Meeting Series. Washington, DC: National Academy of Medicine; 2017
    CrossrefGoogle Scholar
  • 2 Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc 2013; 20 (01) 144-15
    CrossrefPubMedGoogle Scholar
  • 3 Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform 2013; 46 (05) 830-836
    CrossrefPubMedGoogle Scholar
  • 4 Kennell Jr TI, Willig JH, Cimino JJ. clinical informatics researcher's desiderata for the data content of the next generation electronic health record. Appl Clin Inform 2017; 8 (04) 1159-1172
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Wei W-Q, Teixeira PL, Mo H, Cronin RM, Warner JL, Denny JC. Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance. J Am Med Inform Assoc 2016; 23 (e1): e20-e27
    CrossrefPubMedGoogle Scholar
  • 6 Zhao J, Papapetrou P, Asker L, Boström H. Learning from heterogeneous temporal data in electronic health records. J Biomed Inform 2017; 65: 105-119
    CrossrefPubMedGoogle Scholar
  • 7 Kahn MG, Callahan TJ, Barnard J. et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016; 4 (01) 1244
    PubMedGoogle Scholar
  • 8 Bian J, Lyu T, Loiacono A. et al. Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data. J Am Med Inform Assoc 2020; 27 (12) 1999-2010
    CrossrefPubMedGoogle Scholar
  • 9 Multinational Association of Supportive Care in Cancer. MASCC. Available at: https://www.mascc.org/about-mascc
    PubMedGoogle Scholar
  • 10 Sun CC, Bodurka DC, Weaver CB. et al. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 2005; 13 (04) 219-227
    CrossrefPubMedGoogle Scholar
  • 11 Dupuis LL, Boodhan S, Sung L. et al; Pediatric Oncology Group of Ontario. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer 2011; 57 (02) 191-198
    CrossrefPubMedGoogle Scholar
  • 12 Hesketh PJ, Kris MG, Basch E. et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2017; 35 (28) 3240-3261
    CrossrefPubMedGoogle Scholar
  • 13 Patel P, Robinson PD, Thackray J. et al. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: a focused update. Pediatr Blood Cancer 2017; 64 (10) e26542
    CrossrefPubMedGoogle Scholar
  • 14 Dupuis LL, Sung L, Molassiotis A, Orsey AD, Tissing W, van de Wetering M. 2016 updated MASCC/ESMO consensus recommendations: prevention of acute chemotherapy-induced nausea and vomiting in children. Support Care Cancer 2017; 25 (01) 323-331
    CrossrefPubMedGoogle Scholar
  • 15 Dupuis LL, Roscoe JA, Olver I, Aapro M, Molassiotis A. 2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy. Support Care Cancer 2017; 25 (01) 317-321
    CrossrefPubMedGoogle Scholar
  • 16 Patel P, Robinson PD, Orsey A. et al. Chemotherapy-induced nausea and vomiting prophylaxis: practice within the children's oncology group. Pediatr Blood Cancer 2016; 63 (05) 887-892
    CrossrefPubMedGoogle Scholar
  • 17 Navari RM. Management of chemotherapy-induced nausea and vomiting in pediatric patients. Paediatr Drugs 2017; 19 (03) 213-222
    CrossrefPubMedGoogle Scholar
  • 18 Beauchemin M, Cohn E, Shelton RC. Implementation of clinical practice guidelines in the health care setting: a concept analysis. ANS Adv Nurs Sci 2019; 42 (04) 307-324
    CrossrefPubMedGoogle Scholar
  • 19 Beauchemin M, Sung L, Hershman DL, Weng C, Dupuis LL, Schnall R. Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults. Support Care Cancer 2020; 28 (10) 4761-4769
    CrossrefPubMedGoogle Scholar
  • 20 Gomez DR, Liao KP, Giordano S, Nguyen H, Smith BD, Elting LS. Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer 2013; 119 (07) 1428-1436
    CrossrefPubMedGoogle Scholar
  • 21 Check DK, Reeder-Hayes KE, Zullig LL, Weinberger M, Basch EM, Dusetzina SB. Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients. Support Care Cancer 2016; 24 (12) 4839-4847
    CrossrefPubMedGoogle Scholar
  • 22 Horsky J, Drucker EA, Ramelson HZ. Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits. AMIA Annu Symp Proc 2018; 2017: 912-920
    PubMedGoogle Scholar
  • 23 Wright A, McCoy AB, Hickman TT. et al. Problem list completeness in electronic health records: a multi-site study and assessment of success factors. Int J Med Inform 2015; 84 (10) 784-790
    CrossrefPubMedGoogle Scholar
  • 24 Basch E, Prestrud AA, Hesketh PJ. et al; American Society of Clinical Oncology. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2011; 29 (31) 4189-4198
    CrossrefPubMedGoogle Scholar
  • 25 Check DK, Reeder-Hayes KE, Basch EM, Zullig LL, Weinberger M, Dusetzina SB. Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer. Breast Cancer Res Treat 2016; 156 (02) 351-359
    CrossrefPubMedGoogle Scholar
  • 26 Parsons HM, Maguire FB, Morris CR. et al. Impact of insurance type and timing of Medicaid enrollment on survival among adolescents and young adults with cancer. Pediatr Blood Cancer 2020; 67 (09) e28498
    CrossrefPubMedGoogle Scholar
  • 27 Dupuis LL, Taddio A, Kerr EN, Kelly A, MacKeigan L. Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy 2006; 26 (09) 1221-1231
    CrossrefPubMedGoogle Scholar
  • 28 Molassiotis A, Coventry PA, Stricker CT. et al. Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage 2007; 34 (02) 148-159
    CrossrefPubMedGoogle Scholar
  • 29 Schwartzberg LS. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives. J Support Oncol 2007; 5 (02) (Suppl. 01) 5-12
    PubMedGoogle Scholar
  • 30 Baggott CR, Dodd M, Kennedy C. et al. An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. Support Care Cancer 2011; 19 (03) 353-361
    CrossrefPubMedGoogle Scholar
  • 31 Miller E, Jacob E, Hockenberry MJ. Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. Oncol Nurs Forum 2011; 38 (05) E382-E393
    CrossrefPubMedGoogle Scholar
  • 32 Bošnjak SM, Gralla RJ, Schwartzberg L. Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists. Support Care Cancer 2017; 25 (05) 1661-1671
    CrossrefPubMedGoogle Scholar
  • 33 Weiskopf NG, Bakken S, Hripcsak G, Weng C. A data quality assessment guideline for electronic health record data reuse. EGEMS (Wash DC) 2017; 5 (01) 14
    CrossrefPubMedGoogle Scholar
  • 34 Miller RH, Sim I. Physicians' Use Of Electronic Medical Records. Physicians' use of electronic medical records: barriers and solutions. Health Aff (Millwood) 2004; 23 (02) 116-126
    CrossrefPubMedGoogle Scholar
  • 35 Mamykina L, Vawdrey DK, Stetson PD, Zheng K, Hripcsak G. Clinical documentation: composition or synthesis?. J Am Med Inform Assoc 2012; 19 (06) 1025-1031
    CrossrefPubMedGoogle Scholar
  • 36 Basch E, Deal AM, Dueck AC. et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 2017; 318 (02) 197-198
    CrossrefPubMedGoogle Scholar
  • 37 Kotronoulas G, Kearney N, Maguire R. et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 2014; 32 (14) 1480-1501
    CrossrefPubMedGoogle Scholar
  • 38 Fort D, Wilcox AB, Weng C. Could patient self-reported health data complement EHR for phenotyping?. AMIA Annu Symp Proc 2014; 2014: 1738-1747
    PubMedGoogle Scholar
  • 39 Hess J, Vaidya V, Rees M, Walsh A. Implementation of a chemotherapy-induced nausea and vomiting dashboard. J Clin Oncol 2018; 36 (15, suppl): e22519
    CrossrefPubMedGoogle Scholar
  • 40 Jiang G, Solbrig HR, Prud'hommeaux E, Tao C, Weng C, Chute CG. Quality assurance of cancer study common data elements using a post-coordination approach. AMIA Annu Symp Proc 2015; 2015: 659-668
    PubMedGoogle Scholar